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Chronic rhein treatment improves recognition memory in high-fat diet-induced 
obese male mice 
Abstract 
High-fat (HF) diet modulates gut microbiota and increases plasma concentration of lipopolysaccharide 
(LPS) which is associated with obesity and its related low-grade inflammation and cognitive decline. 
Rhein is the main ingredient of the rhubarb plant which has been used as an anti-inflammatory agent for 
several millennia. However, the potential effects of rhein against HF diet-induced obesity and its 
associated alteration of gut microbiota, inflammation and cognitive decline have not been studied. In this 
study, C57BL/6J male mice were fed an HF diet for 8 weeks to induce obesity, and then treated with oral 
rhein (120 mg/kg body weight/day in HF diet) for a further 6 weeks. Chronic rhein treatment prevented the 
HF diet-induced recognition memory impairment assessed by the novel object recognition test, 
neuroinflammation and brain-derived neurotrophic factor (BDNF) deficits in the perirhinal cortex. 
Furthermore, rhein inhibited the HF diet-induced increased plasma LPS level and the proinflammatory 
macrophage accumulation in the colon and alteration of microbiota, including decreasing Bacteroides-
Prevotella spp. and Desulfovibrios spp. DNA and increasing Bifidobacterium spp. and Lactobacillus spp. 
DNA. Moreover, rhein also reduced body weight and improved glucose tolerance in HF diet-induced obese 
mice. In conclusion, rhein improved recognition memory and prevented obesity in mice on a chronic HF 
diet. These beneficial effects occur via the modulation of microbiota, hypoendotoxinemia, inhibition of 
macrophage accumulation, anti-neuroinflammation and the improvement of BDNF expression. Therefore, 
supplementation with rhein-enriched food or herbal medicine could be beneficial as a preventive strategy 
for chronic HF diet-induced cognitive decline, microbiota alteration and neuroinflammation. 
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High-fat (HF) diet modulates gut microbiota and increases plasma concentration of 2 
lipopolysaccharide (LPS), metabolic endotoxemia, which is associated with obesity and its 3 
related low-grade inflammation and cognitive decline. Rhein is the main ingredient of the 4 
rhubarb plant which has been used as an anti-inflammatory agent for several millennia. 5 
However, the potential effects of rhein against HF diet-induced obesity and its associated 6 
alteration of gut microbiota, inflammation and cognitive decline have not been studied. In 7 
this study, C57BL/6J male mice were fed a HF diet for 8 weeks to induce obesity, and then 8 
treated with oral rhein (120 mg/kg body weight per day in HF diet) for a further 6 weeks. 9 
Chronic rhein treatment prevented the HF diet-induced recognition memory impairment 10 
assessed by novel object recognition test, neuroinflammation and BDNF deficits in the 11 
perirhinal cortex. Furthermore, rhein inhibited the HF diet-induced increased plasma LPS 12 
level and the pro-inflammatory macrophage accumulation in the colon and alteration of 13 
microbiota, including decreasing Bacteroides-Prevotella spp. and Desulfovibrios spp. DNA 14 
and increasing Bifidobacterium spp. and Lactobacillus spp. DNA. Moreover, rhein also 15 
reduced body weight and improved glucose tolerance in HF diet-induced obese mice. In 16 
conclusion, rhein improved recognition memory and prevented obesity in mice on a chronic 17 
HF diet. These beneficial effects occur via the modulation of microbiota, hypoendotoxinemia, 18 
inhibition of macrophage accumulation, anti-neuroinflammation and the improvement of 19 
BDNF expression. Therefore, supplementation with rhein-enriched food or herbal medicine 20 
could be beneficial as a preventive strategy for chronic HF diet-induced cognitive decline, 21 
microbiota alteration and neuroinflammation.  22 
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1. Introduction 26 
Obesity is a major risk factor for the development of insulin resistance, type 2 diabetes, and 27 
cognitive decline in neurodegenerative diseases such as Alzheimer’s disease (AD) and 28 
vascular dementia [1, 2]. Patients with AD have been characterized by deficits in recognition 29 
memory [3]. The perirhinal cortex plays an important role in higher object recognition 30 
memory [4]. Lesions in the perirhinal cortex severely disrupt object recognition [5], 31 
object-in-place memory, and temporal order recognition memory [6, 7] in rodent studies. 32 
Empirical evidence has linked high-fat (HF) diet-induced obesity with impairments in 33 
learning and memory, including a decline in recognition memory [8] as assessed with the 34 
novel object recognition test. 35 
Nowadays, it is widely accepted that obesity and its associated cognitive decline is 36 
associated with low-grade systemic and central inflammation, despite the fact that the 37 
molecular origin of the inflammation is poorly understood [9, 10]. Increased fat intake has 38 
been found to be strongly correlated with increased plasma lipopolysaccharide (LPS), 39 
endotoxemia [10]. LPS is a major component of the outer membrane in Gram-negative 40 
bacteria. Emerging evidence from animal studies suggests a link between the alteration of gut 41 
microbiota, increased intestinal permeability, and endotoxemia in HF diet-induced obesity 42 
[11]. An imbalance of Bacteroidetes and Firmicutes, the primary bacterial phyla comprising 43 
the gastrointestinal microbiota, has been reported in rodents fed a HF diet and obese 44 
individuals [12, 13]. The plasma LPS level was closely correlated with altered intestinal 45 
microbiota, in which the number or diversity of the Gram-negative, Bacteroidetes phylum, 46 
were significantly reduced in animals fed a HF diet [14]. The endogenous LPS is considered 47 
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to be continuously produced in the gut by the death of Gram-negative bacteria and its 48 
translocation into intestinal capillaries via the increased intestinal permeability in HF 49 
diet-induced obesity [15]. Endotoxinemia in turn can trigger systemic inflammation and 50 
neuroinflammation. It has been shown that an intraperitoneal (ip) injection of LPS induces 51 
neuroinflammation, cognitive impairment and memory dysfunction [16]. LPS binds to 52 
Toll-like receptor (TLR) 4 coupled with myeloid differentiation primary-response protein 88 53 
(MyD88)-dependent pathway, and activates c-Jun N-terminal kinase (JNK) and nuclear 54 
factor-kappa B (NFκB), two important inflammatory signaling molecules [17]. The activation 55 
of the TLR4-MyD88-JNK/NFκB signaling pathway leads to the production of 56 
pro-inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor 57 
necrosis factor- (TNF-), and contributes to the development of neurodegenerative diseases 58 
[18-21]. 59 
Brain-derived neurotrophic factor (BDNF) is known to play an important role in neuronal 60 
development and synaptic plasticity in the brain regions involved in cognitive function [22]. 61 
In the perirhinal cortex, BDNF has been shown to be important for object recognition 62 
memory [23]. Studies have found that BDNF expression in the perirhinal cortex has a 63 
positive relationship with recognition memory in rats [23, 24], and that treatment with 64 
anti-BDNF serum inhibited long-term recognition memory in rats [25]. An intraperitoneal 65 
injection of IL-1β or LPS significantly decreases BDNF mRNA expression in the rat 66 
hippocampus [26]. Furthermore, the oral administration of antimicrobials in 67 
specific-pathogen-free mice transiently altered the composition of the microbiota and 68 
increased exploratory behavior and the level of BDNF in the brain [27]. Moderate colonic 69 
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inflammation induced anxiety-like behavior and decreased BDNF mRNA expression in the 70 
brain [28]. Our previous study found that a HF diet impaired recognition memory, decreased 71 
BDNF, and increased inflammation in the prefrontal cortex of mice [29]. Notably, numerous 72 
studies have shown that the beneficial effects of prebiotics and probiotics in obesity occur via 73 
the modulation of gut microbial homeostasis [30]. Accordingly, the maintenance of a healthy 74 
gut microbial environment is important for the treatment of obesity and its related BDNF and 75 
cognitive decline. 76 
Rhubarb is usually considered to be a vegetable in western countries. The dried rhubarb 77 
rhizome is an important herbal medicine and has been used for thousands of years. Rhubarb 78 
or extract of rhubarb has been reported to possess antibacterial, anti-inflammation, 79 
antioxidative, antidiabetic, and neuroprotective properties [31, 32]. Rhein (4, 5′- 80 
dihydroxy-anthraquinone-2-carboxylic acid) is the main ingredient of rhubarb. It has been 81 
shown that rhubarb-exposed rats have increased bacterial diversity in the ileum [33]. Several 82 
reports have shown that rhein prevents activation of NF-κB and the ERK1/ERK2 pathway 83 
[34], and inhibits the synthesis and activity of proinflammatory cytokines [35, 36]. It has 84 
been shown that rhubarb-exposed rats have increased bacterial diversity in the ileum [33]. 85 
Rhein has also been reported to be an antibacterial agent which inhibits Staphylococcus 86 
aureus [37]. Previously rhein has been reported to decrease body weight gain and fat 87 
accumulation in HF diet-induced obese mice [38-40]. However, the potential effects of rhein 88 
against alteration of gut microbiota and cognition in HF diet-induced obesity have not been 89 
studied. The present study used a chronic HF diet-induced obese mouse model to investigate 90 
whether rhein supplementation prevents endotoxinemia, alteration of gut microbiota, 91 
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recognition memory decline, body weight gain, and glucose intolerance in these mice. 92 
Furthermore, the neuroinflammatory TLR4-MyD88-JNK/NFκB signaling pathway, 93 
pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β), and neurotrophin BDNF were assessed 94 
in the perirhinal cortex. 95 
 96 
2. Methods 97 
2.1. Animals and treatments 98 
Twenty-four C57Bl/6J male mice (8 weeks old) were obtained from the Australian 99 
Bio-Resource Centre (Moss Vale, NSW), and housed in environmentally controlled 100 
conditions (temperature 22°C, 12 hour light/dark cycle). Eight mice were fed a lab chow diet 101 
as a control (Con group). Sixteen mice were fed a HF diet (HF group) containing 60% fat by 102 
calories (SF13-092; Specialty Feeds, Glen Forrest, WA). After 8 weeks, the 16 mice fed a HF 103 
diet were divided into two groups: 8 mice continued to receive the HF diet, and the other 8 104 
mice received the rhein treatment (HF+R group) for 6 weeks. Rhein was mixed in the HF diet 105 
(dosage: 120 mg/kg body weight per day) [41]. Rhein (98%, C15H8O6, MW = 284.21) was 106 
purchased from Sangon Biotech Co. Ltd, China. Body weight was measured on the last day 107 
in every week. Food intake was recorded on the first day in every week. A weighed amount 108 
of fresh diet was given at the beginning of the dark cycle. The remaining food in the cage 109 
plus spillage were collected and weighed 24 hours later. After 6 weeks of treatment, the novel 110 
object recognition test and the intraperitoneal glucose tolerance test (IPGTT) were carried 111 
out. The mice were asphyxiated in chambers prefilled with CO2 4 days after the tests were 112 
carried out. Plasma, cecal contents and brain tissue were collected, snap frozen and stored at 113 
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-80 °C for further analyses as detailed below. The colon tissue was fixed in 10% buffered 114 
formalin for immunohistochemistry. The study was approved by the University of 115 
Wollongong Animal Ethics Committee (AE13/11) and all animal experiments were 116 
conducted in compliance with the National Health and Medical Research Council Australian, 117 
Code of Practice for the Care and Use of Animals for Scientific Purposes (2004). 118 
 119 
2.2. Real-time PCR (qRT-PCR) to quantify microbial strains from cecal content 120 
The cecal contents of mice were collected immediately after the mice were sacrificed and 121 
stored at -80 ̊C. The QIAamp DNA Stool Minikit (QIAGEN, Germany) was used to extract 122 
DNA from cecal contents according to the manufacturer’s instructions. Group-specific 123 
primers based on 16S rDNA sequences PCR assay were forward Bacteroides- Prevotella, 124 
GAGAGGAAGGTCCCCCAC; reverse Bacteroides-Prevotella, CGCTACTTGGCTGGTTC 125 
AG; forward Lactobacillus, GAGGCAGCAGTAGGGAATCTTC; reverse Lactobacillus, GG 126 
CCAGTTACTACCTCTATCCTTCTTC; forward Bifidobacterium, CGCGTCTGGTGTGA 127 
AAG; reverse Bifidobacterium, CCCCACATCCAGCATCCA; forward Desulfovibrios, CC 128 
GTAGATATCTGGAGGAACATCAG; reverse Desulfovibrios, ACATCTAGCATCCATC 129 
GTTTACAGC. Quantitative real-time PCR was performed in a 20-μL final reaction volume 130 
using a SYBR green I master in a Lightcycler 480 (F. Hoffmann-La Roche Ltd, Switzerland). 131 
Amplification was carried out with 40 cycles of 95°C for 5 seconds, 60°C for 10 seconds, and 132 
72°C for 10 seconds. Each assay was performed in duplicate in the same run. The level of 133 
expression for each gene was calculated using the comparative threshold cycle value (Ct) 134 
method, using the formula 2–ΔΔCt (where ΔΔCt = ΔCt sample - ΔCt reference). The final 135 
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results were expressed as normalized fold values relative to the normal group as described 136 
previously [42]. 137 
 138 
2.3. Lipopolysaccharide (LPS) determination 139 
The concentration of plasma LPS was measured by enzyme-linked immunosorbent assay 140 
(LAL assay kit, Hycult Biotech, The Netherlands). The absorbance at 405 nm was measured 141 
with a spectrophotometer. A measurable concentration ranges from 0.04 to 10 EU/ml. All 142 
samples for LPS measurements were performed in duplicate. 143 
 144 
2.4. Immunohistochemistry 145 
The immunohistochemical staining has been described in our previous work (Dinh et al., 146 
2015). Fixed colon tissues were embedded in paraffin and sectioned at 5 µm. The sections 147 
were rehydrated in xylene and then in graded ethanol solutions. The sections were then 148 
washed in 0.3% H2O2 in methanol for 10 min, blocked with 5% normal rabbit serum or goat 149 
serum, and incubated overnight at 4 °C with primary antibodies. Primary antibodies were 150 
anti-F4/80 (1: 500 dilution; ab6640), anti-CD11c (1: 1000 dilution; ab6640), and anti-CD206 151 
(1: 1000 dilution; ab6640) (all from Abcam Inc, Cambridge, MA). Sections were then washed 152 
3 times with TBST and incubated consecutively with the appropriate biotinylated secondary 153 
antibodies: rabbit anti-rat IgG (1: 500 dilution; ab6733), goat anti-Armenian hamster IgG 154 
H&L (1: 500 dilution; ab5744) and goat anti-rabbit IgG H&L (1: 500 dilution; ab6720) (all 155 
from Abcam Inc, Cambridge, MA) for 30 minutes at room temperature. The sections were 156 
then washed and incubated with streptavidin-HRP polymer conjugate (#2438, Sigma-Aldrich 157 
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Pty. Ltd, Sydney, NSW, Australia) for 30 min at room temperature. The sections were then 158 
washed and developed using the ImmPACT DAB peroxidase substrate kit (#4100, Vector 159 
laboratories Inc., Burlingame, CA, USA) and counterstained with haematoxylin (POCD 160 
Scientific, Artarmon, NSW, Australia). Six fields from three sections of each mouse were 161 
viewed under a Leica microscope and digital photographs were captured. Image J software 162 
was used to quantify the area of F4/80, CD11c, and CD206 immunoreactivity on each fields. 163 
The immunohistochemical staining F4/80, CD11c, and CD206 were quantified as a 164 
percentage of positive area per image. The Immunoreactivity is quantified as the % of pixels 165 
in an area of interest that have intensity greater than the background using Image J computer 166 
software, http://rsb.info.nih.gov/ij/docs/pdfs/examples.pdf. 167 
 168 
2.5. Western blotting 169 
Perirhinal cortexes were dissected and homogenized in a NP-40 lysis buffer. The following 170 
antibodies were used: MyD88 (sc-74532), NFκB (sc-7178), p-JNK (sc-81502), IL-1β 171 
(sc-7884), BDNF (sc-20981), and IL-6 (sc-7920) from Santa Cruz Biotechnology (Santa 172 
Cruz, CA); TNF-α (#11948) and TLR4 (#2219) from Cell Signaling Technology (Beverly, 173 
MA). The bands corresponding to the proteins of interest were scanned and band densities 174 
were analyzed using the automatic imaging analysis system, Quantity One (Bio-Rad 175 
Laboratories, Hercules, CA). All quantitative analyses were compared to the control group. 176 
 177 
2.6. Novel object recognition test  178 
Recognition memory was assessed by performing a novel object recognition test based on 179 
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our group’s previous studies [29]. Briefly, a white open-field square box measuring 55 cm in 180 
length, 55 cm in width, and 35 cm in height was used. The open-field box was located in a 181 
sound proof room, and lit at approximately 14 lux. The experimental procedure consisted of 182 
habituation, training, and retention sessions, which were recorded using a video camera 183 
placed above the open-field box. All objects and the open-field box were cleaned with 70% 184 
ethanol between each mouse. For habituation, mice were individually placed in the box for 5 185 
minutes to explore the environment in the absence of objects. During the training session, two 186 
identical objects (A) were placed at opposing corners of the box, 5 cm from the adjacent wall. 187 
Each mouse was then placed in the middle of the open-field box and left to explore the 188 
objects for 5 minutes. A mouse was considered to be exploring the object if it was sniffing, 189 
touching, or facing the object within 2 cm or less, and measurements were recorded in 190 
seconds. For the retention session, one familiar object (A) was replaced with one novel object 191 
(B) and measurements were taken according to how much time each mouse spent at each 192 
object as per the training session. The retention session commenced upon placing each mouse 193 
in the middle of the open-field box 90 minutes after its training session, and leaving it to 194 
explore for another 5 minutes. Novel object exploration time and the discrimination index (DI 195 
= [(Novel Object Exploration Time/Total Exploration Time) – (Familiar Object Exploration 196 
Time/Total Exploration Time)] × 100) were used to evaluate the recognition memory of 197 
the mice [43].  198 
 199 
2.7. Intraperitoneal glucose tolerance test 200 
Mice were fasted overnight before a glucose tolerance test was performed to assess glucose 201 
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clearance, following an intraperitoneal injection of glucose (0.5 g/kg; Sigma-Aldrich, St 202 
Louis, MO, USA). Blood samples were taken from the tail vein at 0, 15, 30, 60 and 120 203 
minutes following the injection of glucose. Blood glucose was measured using an Accu-Chek 204 
glucometer (Roche Diagnostics GmbH Mannheim, Germany). 205 
 206 
2.8. Statistical analysis 207 
Data were analyzed using the statistical package SPSS 20 (SPSS, Chicago, IL). Data was 208 
first tested for normality before differences among the Con, HF, and HF+R groups were 209 
determined using one-way analysis of variance (ANOVA). This was followed by the post hoc 210 
Tukey-Kramer honestly significant difference (HSD) test for multiple comparisons among the 211 
groups. A p value of <0.05 was considered to be statistically significant. Values are expressed 212 
as mean ± SEM. Pearson’s correlations were used to examine the relationship between the 213 
discrimination index in the novel object recognition test and plasma LPS and BDNF levels in 214 
the perirhinal cortex. 215 
 216 
3. Results 217 
3.1. Rhein reversed the alteration of gut microbiota induced by a HF diet 218 
To investigate the effect of rhein on intestinal microbiota, we used qRT-PCR to evaluate 219 
the abundance of several vital strains of gut flora in the cecal content, including 220 
Bacteroides-Prevotella spp, Lactobacillus spp., Bifidobacterium spp. and Desulfovibrios spp. 221 
A chronic HF diet significantly altered gut microbiota in the HF group compared to the 222 
control group. The amounts of Bacteroides-Prevotella spp. and Desulfovibrios spp. DNA 223 
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were significantly decreased (p < 0.001, p < 0.001), while Bifidobacterium spp. and 224 
Lactobacillus spp. DNA were significantly increased (p < 0.001, p = 0.003) (Fig 1). A 225 
6-week rhein oral treatment reversed the altered gut microbiota induced by the HF diet. The 226 
amount of Bacteroides-Prevotella spp. and Desulfovibrios spp. DNA were significantly 227 
increased in the HF+R group compared to the HF group (p = 0.044, p = 0.044), although the 228 
amount of Bacteroides-Prevotella spp. DNA in the HF+R group was still lower than the 229 
control mice (p < 0.001) (Fig. 1). Meanwhile, the rhein treatment prevented the HF 230 
diet-induced alteration of the amount of Bifidobacterium spp. DNA in the HF+R group 231 
compared to the HF group (p < 0.001). There was no significant difference in 232 
Bifidobacterium spp. DNA between the HF+R group and the control group (p = 0.997) (Fig. 233 
1). The amount of Lactobacillus spp. DNA of the HF+R group was lower than the HF group 234 
(p = 0.003), but there was no significant difference between the HF+R group and the control 235 
group (p = 0.159) (Fig. 1). 236 
 237 
3.2. Rhein decreased plasma LPS concentration in obese mice induced by a HF diet 238 
To further determine whether changes in the gut microbiota could be associated with 239 
systemic inflammation, we measured the plasma concentration of LPS, a trigger of 240 
inflammation. The concentration of plasma LPS was 59% higher in the HF group than the 241 
control group (HF: 1.02±0.12 EU/ml, Control: 0.64±0.11 EU/ml, p < 0.001) (Fig. 2A). The 242 
rhein treatment for 6 weeks prevented an increase of plasma LPS induced by the HF diet (HF: 243 
1.02±0.12 EU/ml, HF+R: 0.64±0.13 EU/ml, p < 0.001). There was no difference between the 244 




3.3. Rhein reduced M1 macrophage accumulation in the colon of HF diet-induced obese mice 247 
To investigate the effect of rhein on macrophage accumulation in the colon of HF diet mice, 248 
we stained macrophages with F4/80 antibody (Fig 2B and C). The positive immunoreactivity 249 
of F4/80 was significantly increased in the colon of obese mice, however this was reduced by 250 
the rhein treatment (Fig. 2B). Furthermore, we characterized the type of macrophages. CD11c 251 
was used to detect M1 macrophages which produce pro-inflammatory cytokines, and CD206 252 
was used to detect M2 macrophages which produce anti-inflammatory cytokines [44, 45]. 253 
Rhein significantly reduced the CD11c positive staining in the colon of obese mice compared 254 
to the obese mice without rhein treatment (Fig. 2B and C). There were no significant 255 
differences in the CD206 staining in the colon of obese mice compared to the obese mice 256 
without rhein treatment (Fig. 2B and C).  257 
 258 
3.4. Rhein suppressed the inflammation in the perirhinal cortex in HF diet-induced obese 259 
mice 260 
To investigate whether endotoxemia could be related to neuroinflammation, we examined 261 
the TLR4-My88-NFκB/JNK signaling pathway and pro-inflammatory cytokines (TNF-α, 262 
IL-6 and IL-1β) in the perirhinal cortex, an important brain region for recognition memory. 263 
Western blotting revealed that the TLR4 and MyD88 level in the perirhinal cortex was 264 
significantly higher in the HF group than the control group (p = 0.049, p < 0.001), while the 265 
TLR4 and MyD88 level was significantly decreased in the HF+R group (rhein treatment 266 
group) compared to the HF group (p = 0.038, p = 0.001) (Fig. 3). There was no statistical 267 
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difference in the TLR4 and MyD88 level between the HF+R group and the control group 268 
(both p > 0.005). Furthermore, the NFκB and p-JNK level was significantly higher in the HF 269 
group compared to the control group (p = 0.047, p = 0.008), while the rhein treatment 270 
prevented an increase of NFκB and p-JNK (p = 0.036, p = 0.003) (Fig. 3). The 271 
pro-inflammatory cytokine IL-1, IL-6, and TNF-α levels were significantly higher in the HF 272 
group compared to the control group (p = 0.025, p = 0.011, p = 0.011) (Fig. 3). The IL-1 and 273 
IL-6 levels were significantly lower in the HF+R group than the HF group (p = 0.032; p = 274 
0.006). However, the rhein treatment did not significantly decrease the TNF-α level.  275 
 276 
3.5. Rhein improved recognition memory and increased BDNF levels in the perirhinal cortex 277 
of HF diet-induced obese mice 278 
To assess whether rhein treatment can prevent HF diet-induced recognition memory 279 
deficits, we performed a novel object recognition test in mice fed a HF diet and given rhein 280 
treatment. During the training session of the test, the percentage of time spent exploring the 281 
identical objects in the open-field was not significantly different among the control group 282 
(18.06%), the HF group (17.05%), and the HF+R group (16.50%). One day after the training 283 
session, all mice were presented with the familiar object and a new object. The exploration 284 
time on the novel object of the HF group was significantly decreased compared to the control 285 
mice (HF: 26.43±3.78 seconds, Control: 31.13±2.98 seconds, p = 0.023) (Fig. 4A), 286 
suggesting that the HF diet significantly impaired novel object recognition performance. 287 
However, the rhein treatment increased novel object exploration time in the HF mice (HF+R: 288 
33.57±3.29 seconds, HF: 26.43±3.78 seconds, p = 0.002) (Fig. 4A). Consistent with the 289 
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result of novel object exploration time, the rhein treatment significantly improved recognition 290 
memory as assessed by the discrimination index. The HF diet decreased the discrimination 291 
index by 60.60% compared to the control group (p = 0.009), while the rhein treatment 292 
increased the discrimination index by 178.57% compared with the HF group (p = 0.013) (Fig. 293 
4B). There was no difference between the HF+R group and the control group in novel object 294 
exploration time and the discrimination index (p = 0.230, p = 0.785). These results show that 295 
recognition memory deficits caused by a HF diet may be prevented by rhein treatment. 296 
We evaluated the effect of rhein on the level of BDNF in the perirhinal cortex of HF diet 297 
fed mice using western blotting analysis. The BDNF level was significantly lower in the HF 298 
group than the control group (p < 0.001) (Fig. 4C), while the rhein treatment significantly 299 
increased the BDNF level in the HF+R group compared to the HF group (p < 0.001). 300 
However, the BDNF level was still lower in the HF+R group than the control group (p = 301 
0.036) (Fig. 4C). Pearson’s correlation analysis revealed a significantly positive correlation 302 
between the discrimination index of the novel object recognition test and the BDNF level in 303 
the perirhinal cortex (r = 0.622, p = 0.008) (Fig. 4D). Furthermore, there was a negative 304 
correlation between the discrimination index value and the plasma LPS level (r = -0.705, p = 305 
0.002) (Fig. 4E). 306 
 307 
3.6. Rhein reduced body weight and food intake, and improved glucose tolerance in HF 308 
diet-induced obese mice 309 
Before the HF diet feeding, there was no significant difference in body weight between the 310 
control group and the HF group (Control: 22.82±1.73 g, HF: 23.06±1.73 g, p > 0.05) (Fig. 311 
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5A). After 8 weeks on the HF diet, the HF group had significant higher body weight than the 312 
control group (HF: 33.11±2.41 g, Control: 25.80±1.56 g, p < 0.05). The rhein treatment 313 
prevented the body weight gain from week 9. After the rhein treatment for 6 weeks, the body 314 
weight was significantly lower in the HF+R group than the HF group (HF+R: 33.37±2.85 g, 315 
HF: 38.22±3.56 g, p < 0.05), although it was still higher than the control group (HF+R: 316 
33.37±2.85 g, Control: 27.47±1.93 g, p < 0.05) (Fig. 5A). Furthermore, the energy intake was 317 
significantly decreased on the first day following rhein treatment compared to the HF diet (p 318 
< 0.001) (Fig. 5B). However, there was no significantly difference in the energy intake for 319 
the remaining 5 weeks of treatment between HF+R and HF group (all p > 0.05).  320 
Glucose tolerance tests were performed to assess glucose homeostasis. The highest blood 321 
glucose level in the HF group and the HF+R group occurred at 30 minutes, while the highest 322 
blood glucose level in the control group occurred at 15 minutes (Fig. 5C). The blood glucose 323 
level of the rhein treatment group significantly decreased at 15, 30, 60, and 120 minutes 324 
compared with the HF group (all p < 0.05), but they were still higher than those of the control 325 
group (all p < 0.05). 326 
 327 
4. Discussion 328 
In this study, we found that a chronic HF diet altered gut microbiota, increased plasma LPS, 329 
increased macrophage accumulation in colon, increased the neuroinflammation response, and 330 
decreased the BDNF level in the perirhinal cortex, and impaired recognition memory in obese 331 
mice. Rhein oral treatment for 6 weeks significantly ameliorated the altered gut microbiota, 332 
lowered plasma LPS, reduced macrophage accumulation, decreased neuroinflammation, and 333 
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increased BDNF in the perirhinal cortex and improved recognition memory in diet-induced 334 
obese mice. 335 
Previous studies have provided compelling evidence to suggest an association between the 336 
gut microbiota, HF diet and body weight regulation [46, 47]. Firmicutes and Bacteriodetes 337 
account for more than 90% of the total gut microbiota [48]. The 8-week HF diet increased 338 
Firmicutes and reduced Bacteriodetes. It has also been reported that the HF diet for 8 weeks 339 
post-weaning changes the microbiota, decreases the overall bacterial abundance, and 340 
increases the ratio of Firmicutes to Bacteriodetes in mice [47]. Ley et al. observed that a 341 
reduced abundance of Bacteroidetes and an increased abundance of Firmicutes were observed 342 
in leptin-deficient obese mice compared with their lean littermates [13]. Consistent with 343 
animal models, a similar difference of an increased ratio of Firmicutes/Bacteroidetes in the 344 
gut microbiota has also been reported in obese humans [49]. In the present study, we found 345 
that a chronic HF diet decreased the DNA level of Bacteroides-Prevotella spp. and increased 346 
the DNA level of Lactobacillus spp. belonging to Bacteroidetes and Firmicutes respectively 347 
at the species level [50]. Therefore, our study at the species level supports the finding from 348 
previous studies at the phylum level that a HF diet alters the microbiota in Bacteroidetes and 349 
Firmicutes [13, 47]. Importantly, we also found that the rhein treatment prevented the 350 
alteration of gut microbiota induced by a HF diet in obese mice, which may contribute to 351 
rhein’s ability to prevent HF diet-induced obesity.  352 
Rhein is the main ingredient of the rhubarb plant. An increased bacterial diversity was 353 
observed in the ileum of rhubarb-exposed rats [33]. The 380 bp product (region of the 354 
Bacteroides genome) was increased in the feces and bowel mucosa of rhubarb-exposed rats 355 
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[33]. Furthermore, rhein has been considered as an antibacterial agent against Staphylococcus 356 
aureus [37]. A synergistic or partial synergistic effect of rhein in combination with ampicillin 357 
or oxacillin against methicillin-resistant Staphylococcus aureus has also been demonstrated 358 
[51]. In the present study, we found that rhein attenuated the HF diet-induced alteration of gut 359 
microbiota. Furthermore, rhein administration prevented the elevation of HF diet-induced 360 
plasma LPS. LPS is a major component of the outer membrane in Gram-negative bacteria. 361 
The plasma LPS level was closely correlated with changes in intestinal microbiota, especially 362 
the numbers of the Gram-negative Bacteroides-like intestinal bacteria which reside within the 363 
Bacteroidetes phylum and were significantly reduced in animals fed the HF diet [14]. The 364 
elevated plasma LPS is related to the over-production of LPS in the gut by the death of 365 
Gram-negative bacteria and their translocation into the bloodstream via an increased 366 
intestinal permeability in HF diet-induced obesity [52]. In the present study, we found that a 367 
chronic HF diet decreased Bacteroides-Prevotella spp. and Desulfovibrios spp. DNA levels, 368 
which belong to the Gram-negative bacterium Bacteroidetes and Proteobacteria respectively. 369 
A deceased Gram-negative bacterium releases LPS which leads to an increased plasma LPS 370 
level in obese mice induced by a HF diet. Furthermore, in the present study, the rhein 371 
treatment prevented the decrease of Gram-negative bacterium (including 372 
Bacteroides-Prevotella spp. and Desulfovibrios spp.) induced by a HF diet. These data 373 
strongly suggest that rhein affects the intestinal microbiota and is responsible for the 374 
attenuation of metabolic endotoxemia in HF diet-induced obesity.  375 
LPS induce macrophage activation and accumulation [53]. M1 macrophages produce 376 
pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, while M2 macrophages 377 
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produce anti-inflammatory cytokines, such as IL-10 [44, 45]. This study showed that there is 378 
an increased level of plasma LPS concentration in obese mice on a chronic HF diet. This is 379 
accompanied by an increased M1 macrophage accumulation in the colon. These results 380 
support previous findings which show that TNF-α expression is significantly increased in the 381 
colon of obese mice [54, 55]. Importantly, our present study shows that rhein treatment 382 
significantly reduced colon inflammation in obese mice on a chronic HF diet.  383 
TLR4 is the receptor for LPS and it plays a critical role in innate immunity [56]. The 384 
stimulation of TLR4 activates the MyD88-dependent pathway to induce NFκB and JNK 385 
activation, which in turn leads to the production of pro-inflammatory cytokines such as 386 
TNF-α, IL-6, and IL-1β [57]. In this study, we detected the activation of the 387 
TLR4-My88-JNK/NFκB inflammatory signaling pathway. We also found an over-expression 388 
of pro-inflammatory cytokines in the perirhinal cortex of mice on a chronic HF diet. It has 389 
previously been shown that peripheral inflammation acutely impairs object location memory 390 
in humans with perirhinal cortex lesions [58]. Importantly, in the present study, rhein 391 
treatment prevented the inflammatory response in the perirhinal cortex of HF diet-induced 392 
obese mice. This suggests that the anti-inflammatory effect of rhein may contribute to its 393 
prevention of recognition memory decline.  394 
BDNF has been shown to be important for object recognition memory in the perirhinal 395 
cortex [23]. Previous studies found that BDNF expression in the perirhinal cortex has a 396 
positive relationship with recognition memory in rats [23, 24]. An intracerebroventricular 397 
injection of anti-BDNF serum inhibited recognition memory and altered Trk receptor and 398 
BDNF levels in the perirhinal cortex in rats [25]. In our study, the rhein treatment prevented 399 
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the HF diet-induced decrease in the BDNF level in the perirhinal cortex in mice. Several 400 
rodent studies have demonstrated that inflammation affects the expression of BDNF within 401 
the brain. For example, after an intraperitoneal injection of IL-1β or LPS, the BDNF mRNA 402 
expression was significantly decreased in the rat hippocampus [26]. A similar reduction of 403 
BDNF at the protein level has also been observed in cortical regions [59]. The negative 404 
impact of inflammation has important implications for pathophysiology such as the decline of 405 
cognitive function. For example, pro-inflammatory cytokines compromise general memory 406 
[60] and spatial memory [61], and increase apoptosis in the brain [62]. Individuals with 407 
obesity or diabetes with low grade inflammation have an increased risk of cognitive decline 408 
[63]. Therefore, the chronic consumption of rhein may lower the neuroinflammation and 409 
increase BDNF in the perirhinal cortex and thus improve recognition memory in HF 410 
diet-induced obesity. 411 
Previous studies have reported that rhein treatment did not significantly influence energy 412 
intake in either HF mice or db/db mice. For example, rhein delivered by gavage, did not 413 
significantly decrease energy intake of HF mice over 6 weeks [64]. While others showed that 414 
food intake was not significantly decreased by the rhein (oral gavage) over 2 weeks in db/db 415 
mice [65]. In the present study, the energy intake of the rhein group only decreased on the 416 
first day following rhein treatment but not thereafter. This initial drop in energy intake may 417 
be due to an adaptation period of transition from the HF diet to HF diet mixed with rhein. 418 
Consistent with rhein’s hypoglycemic effect in streptozotocin-induced diabetic mice [66], our 419 
study showed that rhein has an anti-obesity effect by reducing body weight and improving 420 
glucose intolerance in HF diet-induced obese mice. Cognitive deficits have been observed in 421 
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older people with glucose intolerance or diabetes but these deficits appear to be attenuated by 422 
improving glycemic control [67]. A previous study found that rhein oral treatment decreased 423 
body weight gain with increased oxygen consumption suggesting that rhein increased energy 424 
expenditure [64]. Furthermore, weight loss in obese older people can significantly improve 425 
cognition [68]. Therefore, rhein-induced weight loss and improved glucose metabolism can 426 
contribute to improved recognition memory.  427 
In conclusion, this study demonstrated that rhein can improve recognition memory and 428 
glucose intolerance and prevent weight gain in mice fed a chronic HF diet. The rhein 429 
treatment also prevented the HF diet-induced alterations of gut microbiota, 430 
hyperendotoxinemia, macrophage accumulation in colon, neuroinflammation, and increased 431 
BDNF in the perirhinal cortex in mice. The behavioral and neurochemical improvements 432 
suggest that supplementation with rhein-enriched food could be a promising strategy to 433 
improve HF diet-induced obesity and cognitive decline.  434 
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Figure 1. Bacteroides-Prevotella, Desulfovibrios, Bifidobacterium and Lactobacillus DNA 
expressions in gut microbiota of the control group (Con), high-fat diet group (HF), and HF 
with rhein treatment group (HF+R) (n = 8 per group). * p < 0.05 compared to the Con group, 
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Figure 4. The object exploration time (A) and the discrimination index (B) in the novel 
object recognition test of the control group (Con), high-fat diet group (HF) and HF with rhein 
treatment group (HF+R). (C) The level of BDNF expression in the perirhinal cortex of mice 
(n = 8 per group). The discrimination index in novel object recognition was positively 
correlated with BDNF in the perirhinal cortex (D), and negatively correlated with plasma 
LPS (E). * p < 0.05 compared to the Con group, # p < 0.05 compared to the HF group, values 



















































































Figure 5. Body weight (A), energy intake (B) and glucose tolerance (C) of the control group 
(Con), high-fat diet group (HF) and HF with rhein treatment group (HF+R). * p < 0.05 



































0 15 30 60 120
Con HF HF+R
